Provenance du réseau au premier degré de W. Shawn Carbonell
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
OncoSynergy, Inc.
 OncoSynergy, Inc. Pharmaceuticals: MajorHealth Technology OncoSynergy, Inc. engages in the provision of solutions for treatment-resistant cancer. It develops new class of oncology therapeutics, called Resistance Mechanism Inhibitors (RMIs), it is a multi-action, tumor-agnostic drug platforms that have shown preclinical promise as monotherapy and in strategic combinations. The company was founded by Shawn W. Carbonell, Anne-Marie Carbonell, and Catherine Park in 2011 and is headquartered in Greenwich, CT.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à W. Shawn Carbonell via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|
Statistiques
Internationale
Sectorielle
Opérationnelle
| Founder | 2 |
| Chief Executive Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Chief Operating Officer | 1 |
Relations les plus connectées
| Insiders | |
|---|---|
| Catherine Park | 1 |
| Anne-Marie Carbonell | 1 |
| Ambar Picon | 1 |
- Bourse
- Insiders
- W. Shawn Carbonell
- Connexions Sociétés
